학술논문
Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial)
Document Type
Article
Author
Source
In: Journal of Acquired Immune Deficiency Syndromes . (Journal of Acquired Immune Deficiency Syndromes, 1 November 2023, 94(3):262-272)
Subject
Language
English
ISSN
19447884
15254135
15254135